SIX Swiss Exchange · Healthcare
Invest in DocMorris stock from India
Indian and foreign residents can buy DocMorris (DOCM) shares directly through Paasa.
By Paasa · Updated
DocMorris at a glance
- Price
- CHF 12.39+CHF 0.24 (1.98%)
- Market cap
- CHF 605.73M
- Day range
- CHF 12.13 – CHF 12.75
- P/E
- -7.84
- Dividend yield
- None
- Volume
- 638.12K
- 1 month
- +12.64%
- 6 months
- +194.30%
- YTD
- +106.84%
- 1 year
- +114.36%
- 5 years
- -96.67%
DocMorris statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 1.1B | CHF 1.0B | CHF 969.5M | CHF 931.0M | CHF 1.7B |
| Gross profit | CHF 105.7M | CHF 216.5M | CHF 203.3M | CHF 160.2M | CHF 260.0M |
| Operating income | −CHF 84.3M | −CHF 104.2M | −CHF 75.8M | CHF 40.5M | −CHF 197.5M |
| Net income | −CHF 134.4M | −CHF 97.3M | CHF 82.3M | −CHF 171.1M | −CHF 225.7M |
| Earnings per share | −CHF 2.60 | −CHF 4.06 | CHF 3.47 | −CHF 7.78 | −CHF 11.52 |
| EBITDA | −CHF 39.4M | −CHF 37.0M | −CHF 54.6M | −CHF 109.8M | −CHF 150.8M |
| Total assets | CHF 825.4M | CHF 778.1M | CHF 866.4M | CHF 1.1B | CHF 1.3B |
| Total debt | CHF 288.6M | CHF 312.2M | CHF 330.8M | CHF 528.6M | CHF 525.2M |
| Cash and short-term investments | CHF 149.9M | CHF 95.4M | CHF 104.0M | CHF 156.4M | CHF 278.2M |
| Shareholders' equity | CHF 409.1M | CHF 340.1M | CHF 430.5M | CHF 350.8M | CHF 484.9M |
| Operating cash flow | −CHF 88.3M | −CHF 26.6M | −CHF 87.4M | −CHF 97.3M | −CHF 130.6M |
| Free cash flow | −CHF 90.0M | −CHF 55.2M | −CHF 115.1M | −CHF 156.6M | −CHF 194.1M |
| Capital expenditure | −CHF 1.8M | −CHF 28.6M | −CHF 27.7M | −CHF 59.3M | −CHF 63.5M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| IVF Hartmann | VBSN.SW | CHF 129.50 | CHF 308.39M |
| COLTENE | CLTN.SW | CHF 47.00 | CHF 280.84M |
| Santhera Pharmaceuticals | SANN.SW | CHF 15.08 | CHF 223.66M |
| Ascom | ASCN.SW | CHF 5.80 | CHF 198.14M |
| Newron Pharmaceuticals | NWRN.SW | CHF 8.14 | CHF 169.36M |
| Molecular Partners | MOLN.SW | CHF 3.31 | CHF 124.16M |
| SHL Telemedicine | SHLTN.SW | CHF 1.07 | CHF 39.65M |
| Relief Therapeutics | RLF.SW | CHF 2.89 | CHF 36.28M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in DocMorris from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search DOCM and buy
Find DocMorris by name or by its ticker, DOCM, and place your order.
Why invest in DocMorris from India
What DocMorris does
DocMorris AG is a key player in the pharmaceutical sector, focusing on both online pharmacy services and the wholesale supply of medical and pharmaceutical goods. The company provides a comprehensive selection of items, including prescription and over-the-counter medications, health and wellness products, beauty and personal care lines, dietary supplements, pain relief remedies, and emergency first aid supplies. DocMorris operates in the Medical - Distribution industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy DocMorris stock from India?
Yes. Indian residents and NRIs can buy DocMorris (DOCM) shares directly through Paasa. DocMorris is listed on the SIX Swiss Exchange, in the Medical - Distribution industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell DocMorris shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.